Mga aktibong sangkap na parmasyutiko
| Progestogen at estrogen | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Progesterone | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pagbubuntis | In-house |
Kosher | 145-13-1 |
| Medroxyprogesterone Acetate | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrol acetate | CP/EP/USP | DMF sa proseso | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproterone acetate | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
| Norethisterone |
CP/EP/USP/JP |
DMF sa proseso |
68-22-4 |
| Norethisterone acetate |
EP/USP |
DMF sa proseso |
51-98-9 |
| Norethisterone Enanthate |
In-house |
Sa ilalim ng R&D |
3836-23-5 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Sa ilalim ng R&D | 50-27- 1 |
| Ethinyl estradiol | CP/EP/USP | GMP | 57-63-6 |
| Estradiol Valerate | CP/EP/USP/KP | DMF | 979-32-8 |
| Estradiol Cypionate |
USP | DMF sa proseso |
313-06-4 |
| Promestriene |
In-house |
Sa ilalim ng R&D |
39219-28-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Sa ilalim ng R&D | 129453-61-8 |
| Exemestane | CP/EP/USP | Sa ilalim ng R&D | 107868-30-4 |
| Androgen | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abiraterone acetate | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamide |
In-house |
Sa ilalim ng R&D |
1297538-32-9 |
| Testosterone | CP/EP/USP | CEP/FDA/WC | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | DMF | 58-20-8 |
| Testosterone Enanthate |
USP/JP | Sa ilalim ng R&D |
315-37-7 |
| Testosterone Propionate |
CP/EP/USP/JP |
Sa ilalim ng R&D |
57-85-2 |
| DHEA | FP/In-house | Dmf/wc/kosher | 53-43-0 |
| Clascoterone | In-house | DMF sa proseso | 19608-29-8 |
| Cortical hormone | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenone | EP | Cep sa proseso | 107724-20-9 |
| Methylprednisolone | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
| Fluticasone furoate | CP/EP | DMF sa proseso | 397864-44-7 |
| Mometasone Furoate |
CP/EP/USP |
DMF sa proseso |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
| Deflazacort |
In-house |
Sa ilalim ng R&D |
14484-47-0 |
| Iba | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Oxcarbazepine | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepine acetate | CP/USP | DMF | 236395- 14-5 |
| GANCICLOVIR | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochloride | USP/EP | Cep sa proseso | 175865-59-5 |
| Oseltamivir phosphate | CP/EP/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In-house | Sa ilalim ng R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
| Vibegron |
In-house |
Sa ilalim ng R&D |
1190389-15-1 |
| Escitalopram oxalate | CP/EP/USP | DMF sa proseso | 219861-08-2 |
| Citalopram hydrobromide |
CP/EP/USP |
DMF sa proseso |
59729-32-7 |
| Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
| Lasmiditan succinate | In-house | DMF | 439239-92-6 |
| Luliconazole | In-house | DMF | 187164-19-8 |
| Nintedanib esylate |
In-house |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Sa ilalim ng R&D | 171596-29-5 |
| Relugolix | In-house | DMF sa proseso | 737789-87-6 |
| Ruxolitinib phosphate |
In-house |
DMF sa proseso |
1092939-17-7 |
| Abemaciclib |
In-house |
Sa ilalim ng R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
| 1,3,5-trimethoxybenzene |
Cp/in-house |
GMP |
621-23-8 |
| Ursinoxycholic acid | EP/USP/JP | Sa ilalim ng R&D | 128-13-2 |
| Tauroursinoxycholic acid |
In-house |
Sa ilalim ng R&D |
14605-22-2 |
| Kolesterol |
CP/EP/USP/JP |
Sa ilalim ng R&D |
57-88-5 |
| Omega-3-acid ethyl eter 90 |
EP/USP |
DMF sa proseso |
—— |
| Medium-chain triglycerides |
CP/USP/EP |
DMF |
—— |
| Benzalkonium chloride |
USP/EP/JP |
Cep sa proseso |
8001-54-5 |
| Langis ng oliba (para sa iniksyon) |
CP/USP/EP/JP |
DMF sa proseso |
8001-25-0 |
| Egg phospholipids (para sa iniksyon) |
CP/USP/EP |
DMF |
93685-90-6 |
| Meryenda |
In-house |
DMF sa proseso |
203787-91-1 |
Ang Testosterone ay may mga detalye ng CP,EP at USP. Available ang CEP, DMF, WC, FDA..
Ang Testosterone undecanoate ay may CP specification.TP available at DMF under filing.
Ang Testosterone Cypionate ay may USP specification.TP available at DMF under filing.
Ang DHEA (Prasterone) ay may FP at In-house na detalye. Available ang DMF at WC.
Ang Gestodene ay may CP at EP na detalye. Available ang DMF, GMP.
Ang Ethinyl Estradiol ay may mga detalye ng USP, EP at CP. Available ang DMF at GMP.